HD, D., MB, T., MB, H., NT, T., NT, V., BB, Q., . . . TK, D. (2025). Long-Term Survival and Prognostic Factors of Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancer reports (Hoboken, N.J.), 8(5), e70212. https://doi.org/10.1002/cnr2.70212
Chicago Style (17th ed.) CitationHD, Duc, Thanh MB, Hong MB, Tien NT, Van NT, Quang BB, Dinh NC, and Doan TK. "Long-Term Survival and Prognostic Factors of Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Hepatocellular Carcinoma." Cancer Reports (Hoboken, N.J.) 8, no. 5 (2025): e70212. https://doi.org/10.1002/cnr2.70212.
MLA (9th ed.) CitationHD, Duc, et al. "Long-Term Survival and Prognostic Factors of Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Hepatocellular Carcinoma." Cancer Reports (Hoboken, N.J.), vol. 8, no. 5, 2025, p. e70212, https://doi.org/10.1002/cnr2.70212.